scholarly journals RETROSPECTIVE ANALYSIS OF PRIMARY EXTRANODAL NON HODGKINS LYMPHOMA- 3 YEARS STUDY AT A TERTIARY CARE INSTITUTE.

2019 ◽  
Vol 7 (3) ◽  
pp. 948-956
Author(s):  
Soma yadav ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 97-100
Author(s):  
Mayanglambam Ronita Devi ◽  
Helen Kamei ◽  
Madhuri Laishram ◽  
Umalakshmi Lairellakpam ◽  
Kimthianmuang Guite ◽  
...  

2017 ◽  
Vol 4 (4) ◽  
pp. 1184
Author(s):  
A. P. Dubey ◽  
Rajeshwar Singh ◽  
Abhishek Pathak ◽  
S. Viswanath ◽  
Anvesh Rathore ◽  
...  

Background: Non Hodgkins lymphoma is the most prevalent hematopoietic neoplasm, representing approximately 4% of all cancer diagnoses and ranking seventh in frequency among all cancers. Most of the data that we have is of west and data pertaining to Indian subcontinent is lacking. The aim of this study was to study clinical profile, prognostication, and assess treatment outcome in DLBCL patients in a tertiary care hospital.Methods: 100 patients of DLBCL reporting to a tertiary care hospital between 2013 to 2016 were chosen for the study. All patients were subjected to routine investigation and specialized investigation including bone marrow examination and Positron emission tomography. Patients were treated with standard treatment protocol and their response to treatment were assessed.Results: Study revealed male predominance with median age of onset was 45.6. Anorexia was the most common symptom. Lymphadenopathy was the most common sign. Bone marrow involvement and anemia commensurate each other. Only16% cases presented in IPI score 4 and 5. Complete remission achieved with treatment in stage l and ll disease were beyond 90% and steep decline in complete remission with treatment was noted in stage lll and lV (~70%). 76% patients with DLBCL showed CR, 12.5% showed PR.Conclusions: The present study revealed male preponderance with relatively early age of onset compared to western population. B- cell lymphoma (DLBCL) constituted maximum number of NHL cases (89%). We have found a higher proportion of B cell subtype as compared to other Indian studies, at the same time it corroborated with the findings of western studies. Complete remission achieved with treatment in stage l and ll disease were beyond 90% and steep decline in complete remission with treatment was noted in stage lll and lV (~70%).


Author(s):  
Raja Pramanik ◽  
Harish Kancharla ◽  
Sameer Bakhshi ◽  
Atul Sharma ◽  
Ajay Gogia ◽  
...  

Author(s):  
Rahul Sud ◽  
Kishore Kumar ◽  
A. P. Dubey ◽  
Sagar Bhagat

Background: A number of environmental and chemical factors have been thought to been implicated in the occurrence of Non-Hodgkin’s Lymphomas (NHLs).To fill the knowledge gap in various aspect of the disease, this study was undertaken at this tertiary care centre in Delhi and Bangalore.Methods: This was a prospective observational study conducted in two defenses medical centre in India among patients of Non Hodgkins Lymphoma, registered at Command hospital Airforce Bangalore and Army Hospital (Research and Referral), New Delhi, between March 2016 and March 2019.Results: The disease showed a bimodal onset in both centres with 26 (26%) and 24 (24%) cases occurring in the age group of 31-40 years and 24 (24%) and 25 (25%) cases occurring in the age group of >60 years at CHAF (B) and AH (RR) respectively. B cell Lymphoma was the most common type of NHL seen in 85% and 89% patients, whereas T-cell lymphomas constituted 13% and 11% at CHAF (B) and AH (RR).  32(32%) patients presented with an Ann Arbor Stage 1 or 2 disease whereas 68(68%) patients were with Stage 3 or 4 disease at both the centers. IPI score was ≥3 in 45 % and 43% patients.Conclusions: NHL in India is a homogeneous and uniform disease. But there was increased detection of hepatosplenomegaly and associated hepatitis B/C in the southern part of India. Also, the occurrence of Cutaneous T cell lymphoma was only seen in the south India centre. The early stage NHLs has better survival and increase chance of complete response.


2019 ◽  
Vol 11 (1) ◽  
pp. 40-45
Author(s):  
Nagesh Vyenktesh Gaddam ◽  
◽  
Smita Maharudrappa Chakote ◽  
Ajay Govindrao Ovhal ◽  
◽  
...  

Sign in / Sign up

Export Citation Format

Share Document